Irritable Bowel Syndrome
Irritable Bowel Syndrome (IBS) is a common digestive disorder that affects how your intestines function, leading to symptoms such as abdominal pain, bloating, and changes in bowel habits like diarrhea or constipation.
Irritable Bowel Syndrome: Symbioflor®2 Treatment
We are studying an oral treatment with living bacteria for people with diarrhea-predominant irritable bowel syndrome (IBS-D). The goal is to see if it helps reduce symptoms compared to a placebo.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you at least 18 years old?
- Do you have irritable bowel syndrome (IBS) with symptoms like abdominal pain and diarrhea?
- Are you currently pregnant or breastfeeding?
- Have you had any abdominal surgery in the last 6 months?
- Are you taking any medications for IBS treatment, like probiotics?
What similar medicines might you know?
Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.
Boncoli
Symbioflor
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Sozialstiftung Bamberg
Klinik für Integrative Medizin und Naturheilkunde
Bamberg, Germany
Velocity Clinical Research Hamburg GmbH
--
Barsbüttel, Germany
Analyze & Realize GmbH
--
Berlin, Germany
Sponsor: SymbioPharm GmbH
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.